Shares of Fractyl Health, Inc. (NASDAQ:GUTS – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $6.51 and last traded at $6.57. 69,309 shares were traded during trading, a decline of 82% from the average session volume of 383,212 shares. The stock had previously closed at $6.64.
Wall Street Analyst Weigh In
GUTS has been the topic of several recent analyst reports. Evercore ISI started coverage on shares of Fractyl Health in a report on Wednesday, February 28th. They issued an “outperform” rating on the stock. Morgan Stanley began coverage on Fractyl Health in a report on Tuesday, February 27th. They issued an “overweight” rating and a $18.00 price objective on the stock. Finally, Bank of America started coverage on Fractyl Health in a research note on Tuesday, February 27th. They set a “buy” rating and a $26.00 target price for the company.
Get Our Latest Analysis on Fractyl Health
Fractyl Health Stock Performance
Insider Activity
In related news, Director Ajay Royan acquired 333,333 shares of the stock in a transaction that occurred on Tuesday, February 6th. The stock was purchased at an average price of $15.00 per share, with a total value of $4,999,995.00. Following the transaction, the director now owns 1,251,900 shares of the company’s stock, valued at approximately $18,778,500. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
About Fractyl Health
Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Further Reading
- Five stocks we like better than Fractyl Health
- 3 Small Caps With Big Return Potential
- Comprehensive PepsiCo Stock Analysis
- What Are Dividends? Buy the Best Dividend Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Fractyl Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fractyl Health and related companies with MarketBeat.com's FREE daily email newsletter.